Table 1.

${\mathrm{IC}}_{50,\mathrm{drug}}$, ${\mathrm{IT}}_{50,\mathrm{HT}}$ and combination doses between hyperthermia for 24 h and 5-fluorouracil, gemcitabine, and cisplatin.

			BxPC-3			PANC-1			Capan-1			Capan-2			MIA-PaCa-2
Drug	Time	$${\mathit{T}}_{\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{T}}_{50,\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$${\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$$\mathit{I}{\mathit{T}}_{50,\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$${\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$$\mathit{I}{\mathit{T}}_{50,\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$${\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$$\mathit{I}{\mathit{T}}_{50,\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$${\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$$\mathit{I}{\mathit{T}}_{50,\mathit{H}\mathit{T}} (°\mathbf{C})$$	$$\mathit{I}{\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$	$${\mathit{C}}_{50,\mathit{d}\mathit{r}\mathit{u}\mathit{g}} (\mu \mathbf{M})$$
5-Fluorouracil	24 h	40.5	41	5.04	0.90	41.5	9.11	1.63	41	0.26	0.018	41.9	41.36	13.57	41.45	5.9	4.70
		41			0.04			0.12			0.0036			6.03			2.37
		41.5			0.00015			0.13			0.0002			1.18			0.03
Gemcitabine	24 h	40.5	41	0.06	0.01	41.5	19.34	0.20	41	0.06	0.0055	41.9	0.40	0.28	41.45	0.12	0.10
		41			0.0016			0.05			0.0013			0.08			0.06
		41.5			0.00006			-			0.0002			0.015			0.0008
Cisplatin	24 h	40.5	41	1.40	0.12	41.5	12.11	1.03	41	0.27	0.017	41.9	0.27	0.017	41.45	5.59	2.72
		41			0.0016			0.06			0.005			0.0053			0.33
		41.5			0.00012			0.014			0.0007			0.0007			0.0007